Global Cord Blood




MarketCap HK

HK Hong Kong


Global Cord Blood Corporation, together with its subsidiaries, provides umbilical cord blood storage and ancillary services in the People's Republic of China. The company offers cord blood testing, processing, and storage services under the direction of subscribers; and tests, processes, and stores donated cord blood, as well as provides matching services. As of March 31, 2022, it operated three cord blood banks, including one in the Beijing municipality; one in the Guangdong province; and one in the Zhejiang province. The company was formerly known as China Cord Blood Corporation and changed its name to Global Cord Blood Corporation in March 2018. Global Cord Blood Corporation is based in Central, Hong Kong. Global Cord Blood Corporation operates as a subsidiary of Blue Ocean Structure Investment Company Ltd.


Global Cord Blood Corporation was established in 1992 as the first cord blood bank in China and is the first publicly listed cord blood banking operator in the world. With a robust quality assurance program and a planned national network of operating and service centers, the Company achieved unprecedented expansion in China's rapidly growing cord blood banking industry.

Our mission is to provide quality cord blood banking service in order to maximize the potential benefit of cord blood stem cells for patients.

Our vision is to be the global leader of cord blood stem cell banking and regenerative medicine, building a bridge between healthcare and future of regenerative medicine.

Key Team

Ms. Rui Arashiyama (Chief Exec. Officer of Guangdong & Zhejiang Divisions)

Ms. Cathy Bai (VP of Corp. Fin.)

Recognition and Awards
Global Cord Blood Corporation has received numerous awards including the World Cord Blood Bank Award, Quality Health Management Award, Quality Management Certificate, and China Top Ten Quality Enterprise award.

Global Cord Blood
Leadership team

Ms. Ting Zheng (CEO & CEO of Beijing Division)

Mr. Bing Chuen Chen (Chief Financial Officer)

Ms. Xin Xu (Chief Technology Officer)

Products/ Services
Biotechnology, Health Care, Hospital, Life Science, Medical
Number of Employees
1,000 - 20,000
Central, Hong Kong Island, Hong Kong
Company Registration
SEC CIK number: 0001467808
Net Income
20M - 100M
100M - 500M
Traded as
Fri Mar 01 2024

businessabc offers a global business, SMEs wiki directory blockchain, NFTs, AI powered marketplace for businesses worldwide.

Follow Us
Produced by
In collaboration with

Copyright 2023 © businessabc powered by ztudium